BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 10:18:00 AM | Browse: 892 | Download: 907
Publication Name World Journal of Clinical Urology
Manuscript ID 3225
Country Japan
Received
2013-04-15 09:22
Peer-Review Started
2013-04-16 09:43
To Make the First Decision
2013-05-14 18:46
Return for Revision
2013-05-17 10:23
Revised
2013-05-31 01:12
Second Decision
2013-06-09 13:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-06-10 04:32
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-06-26 13:02
Publish the Manuscript Online
2013-07-25 09:45
ISSN 2219-2816 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Autobiography
Article Title Potential of metastin and metastin receptor as biomarkers for urological cancers
Manuscript Source Invited Manuscript
All Author List Sunao Shoji, Haruhiro Sato, Tetsuro Tomonaga, Hakushi Kim, Shuichi Soeda, Mayura Nakano, Toyoaki Uchida, Toshiro Terachi and Koichi Takeya
Funding Agency and Grant Number
Corresponding Author Sunao Shoji, MD, PhD, Department of Urology, Tokai University Hachioji Hospital, 1838 Ishikawa-machi, Hachioji, Tokyo 192-0032, Japan. sunashoj@mail.goo.ne.jp
Key Words KISS-1; Metastin; Metastin receptor; Metastasis; Renal cell carcinoma; Upper tract urothelial carcinoma; Bladder cancer
Core Tip Metastin and metastin receptor have attracted interest in the field of cancer because of their novelty and potential to inhibit cancer metastasis. Furthermore, they have potential as suitable molecular biomarkers for urological cancers. However, the results of all of the studies analyzed in this review were retrospectively obtained. Therefore, future studies of metastin and metastin receptor should undergo external validation to ensure consistency across different patient series, since individual institutional studies lack generalization.
Publish Date 2013-07-25 09:45
Citation Shoji S, Sato H, Tomonaga T, Kim H, Soeda S, Nakano M, Uchida T, Terachi T, Takeya K. Potential of metastin and metastin receptor as biomarkers for urological cancers. World J Clin Urol 2013; 2(2): 10-14
URL http://www.wjgnet.com/2219-2816/full/v2/i2/10.htm
DOI http://dx.doi.org/10.5410/wjcu.v2.i2.10
Full Article (PDF) WJCU-2-10.pdf
Manuscript File 3225-Review.docx
Answering Reviewers 3225-Answering reviewers.pdf
Copyright License Agreement 3225-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 3225-Language certificate.pdf
Peer-review Report 3225-Peer reviews.pdf
Scientific Editor Work List 3225-Scientific editor work list.doc